We just received data on a new analyst forecast for $IMRX. Andrew Berens from Leerink Partners set a price target of 15.0 for IMRX.
To track analyst ratings and price targets for $IMRX, check out Quiver Quantitative's $IMRX forecast page.
$IMRX Price Targets
Multiple analysts have issued price targets for $IMRX recently. We have seen 6 analysts offer price targets for $IMRX in the last 6 months, with a median target of $13.0.
Here are some recent targets:
- Andrew Berens from Leerink Partners set a target price of $15.0 on 10/31/2025
- Ami Fadia from HC Wainwright & Co. set a target price of $11.0 on 09/30/2025
- Geulah Livshits from Chardan Capital set a target price of $20.0 on 09/26/2025
- Jay Olson from Oppenheimer set a target price of $30.0 on 09/25/2025
- Ami Fadia from Needham set a target price of $11.0 on 09/15/2025
- Graig Suvannavejh from Mizuho set a target price of $10.0 on 06/18/2025
$IMRX Insider Trading Activity
$IMRX insiders have traded $IMRX stock on the open market 18 times in the past 6 months. Of those trades, 18 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $IMRX stock by insiders over the last 6 months:
- PETER FEINBERG has made 4 purchases buying 45,000 shares for an estimated $201,842 and 0 sales.
- THOMAS J. SCHALL has made 2 purchases buying 49,985 shares for an estimated $124,065 and 0 sales.
- BENJAMIN J. ZESKIND (PRESIDENT AND CEO) has made 3 purchases buying 31,000 shares for an estimated $85,023 and 0 sales.
- BRETT MATTHEW HALL (CHIEF SCIENTIFIC OFFICER) has made 2 purchases buying 13,422 shares for an estimated $34,616 and 0 sales.
- DIANA HAUSMAN has made 2 purchases buying 5,500 shares for an estimated $19,862 and 0 sales.
- LEAH R NEUFELD (CHIEF PEOPLE OFFICER) has made 2 purchases buying 1,500 shares for an estimated $7,602 and 0 sales.
- MICHAEL BOOKMAN (CHIEF LEGAL OFFICER, SECRETARY) purchased 1,020 shares for an estimated $6,966
- HAROLD EUGENE BRAKEWOOD (Chief Business Officer) purchased 1,900 shares for an estimated $4,804
- MALLORY MORALES (Chief Accounting Officer) purchased 300 shares for an estimated $1,917
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IMRX Hedge Fund Activity
We have seen 23 institutional investors add shares of $IMRX stock to their portfolio, and 14 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 659,009 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,220,860
- IRIDIAN ASSET MANAGEMENT LLC/CT added 275,086 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,925,602
- MORGAN STANLEY removed 266,132 shares (-57.0%) from their portfolio in Q2 2025, for an estimated $896,864
- MARSHALL WACE, LLP removed 234,105 shares (-29.0%) from their portfolio in Q2 2025, for an estimated $788,933
- FMR LLC added 221,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $744,770
- BLACKROCK, INC. added 106,228 shares (+33.6%) to their portfolio in Q2 2025, for an estimated $357,988
- MANUFACTURERS LIFE INSURANCE COMPANY, THE removed 82,667 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $278,587
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
